Now showing items 1-3 of 3

    • Caspases as therapeutic targets 

      Howley, B.; Fearnhead, H.O. (Wiley-Blackwell, 2008-09-01)
      The development of small molecules to modulate caspase activity offers a novel therapeutic strategy in the treatment of apoptosis-related and inflammatory diseases. Caspases are key mediators of apoptosis and inflammation; ...
    • End stage kidney disease from scleroderma in the united states, 1996 to 2012 

      Sexton, Donal J.; Reule, Scott; Foley, Robert N. (Elsevier BV, 2017-09-01)
      Introduction: Although the management of scleroderma continues to evolve, it is unknown whether the burden of end-stage kidney disease (ESKD) treated with maintenance renal replacement therapy from SD has changed. Methods: ...
    • Page kidney: etiology, renal function outcomes and risk for future hypertension 

      Smyth, Andrew; Collins, C. Scott; Thorsteinsdottir, Bjorg; Madsen, Bo Enemark; Oliveira, Guilherme H.M.; Kane, Garvan; Garovic, Vesna D. (Wiley-Blackwell, 2012-03-12)